Delivery Order SPE2DB24D2100-SPE2DB25FBFHS
- Not listed
- The Defense Logistics Agency awarded a $4,165.68 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed price delivery under a non-competitive set-aside arrangement and is scheduled for completion by July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and holds a substantial $999.999 billion...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,909.24, is for the supply of REPATHA 140 MG/ML SURECLICK medication. The order is a firm-fixed-price contract with an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at approximately $590 to provide Repatha 140 mg/ml SureClick prefilled syringes. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from July 12 through July 13, 2023. The Defense Logistics Agency routinely utilizes the Prime Vendor Program to fulfill pharmaceutical requirements for the Department of Defense and this order...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $1,804.96 worth of Repatha 140 mg/mL SureClick medication. The contract has a completion date of February 1, 2024 and was awarded on January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract with a...
- The Defense Logistics Agency has awarded a delivery order valued at $4,865.38 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's...
- The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,111.53 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a cardiovascular medication, with a completion date of May 17, 2023. This award is a discrete delivery order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Repatha 140 mg/mL SureClick medication. The $1,298.23 order has a completion date of February 14, 2024 and was awarded on February 13, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,351.83 firm fixed-price contract is for the delivery of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product. The contract has an ultimate completion date of June 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide REPATHA 140 MG/ML SURECLICK 1ML medication. The $7,661.87 delivery order was issued under an existing $999,999,999.00 indefinite delivery contract between DLA and AmerisourceBergen Drug Corp. This contract serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFHSDelivery Order
The Defense Logistics Agency awarded a $4,761.52 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick, a PCSK9 inhibitor used in cardiovascular disease management. This contract, awarded on July 18, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order was competitively awarded with no set-aside designation and includes performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of July 21, 2025. AmerisourceBergen Drug Corp functions as a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems. The company's DLA prime contract serves as a comprehensive global pharmaceutical support vehicle, enabling supply of specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support worldwide military healthcare programs. This delivery order exemplifies AmerisourceBergen's ongoing role in supporting the Defense Health Agency and other federal healthcare systems through the flexible Pharmaceutical Prime Vendor program structure, which is anticipated to transition to Generation V contracts with multiple regional awards in the coming years.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 7/18/25 |